For this reason, we selected the time point showing the best discrimination between HER2-positive and HER2-negative tumours in previous studies, i.e., 2 h after injection for [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 [9,10]. This evidence concerns the gene ERBB2 and neoplasm.